Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18401,147,1.13 [0.84-1.52],0.4138204737337729
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19348,197,1.15 [0.90-1.47],0.261049239814193
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19122,1393,0.90 [0.80-1.01],0.0779193654787397
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19362,436,1.13 [0.95-1.33],0.1640427828147993
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18726,3408,0.97 [0.91-1.05],0.4741137421789081
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18709,3465,0.98 [0.91-1.05],0.5917154012523778
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19123,1151,1.00 [0.89-1.12],0.9956940905348556
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19278,105,1.16 [0.83-1.61],0.3945741049315472
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17093,1013,1.03 [0.91-1.17],0.6378327499235678
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16480,1222,0.91 [0.81-1.04],0.1657582526346369
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16125,258,0.98 [0.76-1.27],0.8745324377948382
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12618,2181,0.98 [0.89-1.07],0.6016831587806175
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16082,392,0.92 [0.74-1.15],0.4633248383874914
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19330,1358,1.02 [0.92-1.14],0.7087736133017427
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,19429,503,1.09 [0.93-1.28],0.2885954366548486
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18710,981,0.96 [0.84-1.10],0.5523851123159812
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19372,1118,1.05 [0.94-1.18],0.3617520171541368
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18169,197,1.15 [0.90-1.47],0.2603393973336275
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19479,49,0.51 [0.22-1.16],0.1089148152230987
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19232,978,1.04 [0.92-1.17],0.5651643738941841
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19234,61,1.19 [0.79-1.82],0.4063381239489286
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19428,108,0.87 [0.57-1.34],0.5365699645677027
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19414,94,0.79 [0.48-1.29],0.3468762812686261
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18107,378,0.73 [0.57-0.95],0.019276621256833
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,17980,251,0.83 [0.62-1.12],0.2162331013030572
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18074,102,0.76 [0.47-1.24],0.2743258562039193
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19464,45,0.75 [0.36-1.58],0.4544156787245239
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19419,151,1.01 [0.73-1.39],0.9507269055576708
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,19316,48,1.25 [0.80-1.93],0.3245170962620143
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19340,72,0.83 [0.48-1.44],0.516942442816982
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,19234,218,1.13 [0.89-1.43],0.3104239827587957
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19406,36,1.08 [0.59-1.99],0.7951256574877565
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19392,41,0.75 [0.34-1.63],0.465532547564583
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9195,71,1.22 [0.83-1.78],0.3131884037431832
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19094,1394,1.03 [0.93-1.15],0.5316884390744656
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of meninges,19465,55,0.96 [0.55-1.68],0.8922186645348017
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19402,68,1.12 [0.73-1.71],0.609048295981458
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19456,100,0.99 [0.66-1.48],0.9737399672683488
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of ovary,10232,65,1.27 [0.89-1.82],0.1919511400381519
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19445,376,0.90 [0.72-1.13],0.3770653357242027
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,19458,318,0.98 [0.78-1.24],0.8951849695710895
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19357,73,1.36 [1.00-1.86],0.0521855382137494
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,19444,217,0.89 [0.66-1.20],0.4489830680882659
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,19402,342,0.90 [0.71-1.14],0.3642789886655528
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19346,579,1.17 [1.02-1.35],0.030130499786778
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19438,445,1.00 [0.82-1.21],0.9622963361494268
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Carcinoma in situ of breast,7710,44,1.17 [0.71-1.93],0.530156577599249
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7741,52,0.91 [0.51-1.63],0.7595432538007262
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",13973,61,0.42 [0.19-0.90],0.0255775211627348
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",13993,81,0.97 [0.62-1.53],0.9118732180193854
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19430,109,0.85 [0.55-1.31],0.4555827590235394
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",19431,106,0.85 [0.55-1.33],0.4843990176726408
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Leiomyoma of uterus,10002,147,0.86 [0.59-1.24],0.4080559141904488
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,12433,421,1.06 [0.89-1.27],0.5179687565901349
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lymphoid leukaemia,13975,63,0.49 [0.24-1.02],0.0580724537673541
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14098,186,0.76 [0.53-1.08],0.1289492643423582
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14169,257,1.07 [0.85-1.34],0.5723842992000057
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7826,99,1.02 [0.69-1.52],0.9155529676420776
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14003,91,0.91 [0.57-1.43],0.6761000104486208
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14029,117,0.84 [0.55-1.28],0.4094694720585676
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14019,107,1.10 [0.78-1.56],0.5753514212425246
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7802,75,1.30 [0.92-1.84],0.1347816408390257
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14022,110,1.21 [0.90-1.64],0.2079023864634969
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6987,802,0.87 [0.74-1.02],0.0828851753588431
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14026,114,0.97 [0.66-1.43],0.8854217868681294
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",13989,77,0.92 [0.56-1.50],0.737435922196366
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14028,116,1.04 [0.74-1.48],0.8056388673233222
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,19354,159,1.15 [0.87-1.50],0.3236370130741758
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,19456,67,0.94 [0.56-1.58],0.8237261751748426
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanoma in situ,13959,100,0.55 [0.31-0.96],0.0354751851776418
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14013,101,0.87 [0.56-1.35],0.5339639102435956
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14080,168,0.82 [0.57-1.17],0.2730483947797046
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14207,295,1.01 [0.80-1.27],0.9300547327738304
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14022,110,1.02 [0.70-1.48],0.9107611061234876
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,19332,144,1.22 [0.94-1.58],0.1447322295916171
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15137,1225,0.99 [0.88-1.11],0.8177401265500186
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15203,1291,0.98 [0.87-1.09],0.6887374056972808
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19224,318,1.22 [1.02-1.46],0.0326867299332784
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17597,107,0.90 [0.59-1.38],0.6369134590893658
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,18965,59,0.62 [0.30-1.25],0.1787462617513984
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,18878,2863,1.00 [0.93-1.08],0.9674608317270784
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18087,59,0.64 [0.32-1.29],0.2132912897279693
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19092,57,0.87 [0.48-1.58],0.6471138765628406
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19088,1598,1.02 [0.92-1.12],0.7317743796568215
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19086,1596,1.02 [0.92-1.12],0.7152858700633977
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17585,95,1.11 [0.76-1.60],0.5940263194641571
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19182,1154,0.99 [0.88-1.11],0.8394809092757491
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19137,102,0.70 [0.42-1.17],0.1727470579677518
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,18962,56,0.91 [0.51-1.63],0.743763360570799
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,18975,69,0.61 [0.32-1.18],0.1424002474876577
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19321,286,0.89 [0.68-1.16],0.3823074973027346
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19373,31,1.10 [0.58-2.09],0.7673857256261992
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19268,233,0.95 [0.72-1.25],0.7144021460028515
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18141,113,1.06 [0.74-1.50],0.7571325528453883
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13170,328,1.09 [0.88-1.34],0.4400729186817274
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18229,87,0.92 [0.58-1.47],0.7335870483153519
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18231,89,1.21 [0.85-1.73],0.2939373059745911
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12902,60,1.14 [0.71-1.81],0.5894290228306782
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18147,42,1.09 [0.62-1.91],0.7695274953545137
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17534,261,1.01 [0.78-1.30],0.9557532838067156
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18854,737,0.88 [0.74-1.03],0.1181534540355257
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18516,399,0.77 [0.60-0.99],0.0396068520263436
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18257,140,0.82 [0.55-1.22],0.3252293639340328
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19259,1154,1.02 [0.91-1.14],0.7388093795390148
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16480,1125,1.03 [0.92-1.16],0.6284494757594287
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",12911,69,1.17 [0.77-1.79],0.4583404493078303
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17603,87,1.04 [0.69-1.56],0.8550738698272795
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13143,301,0.91 [0.70-1.17],0.4597057732245381
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12891,49,1.09 [0.64-1.87],0.7514768415257127
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16648,3806,0.99 [0.93-1.06],0.8485684261392923
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13069,227,0.78 [0.57-1.08],0.1370856929937205
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13432,590,0.89 [0.74-1.07],0.2281160795185947
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19433,298,0.99 [0.78-1.25],0.9206779096773549
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19252,117,1.11 [0.80-1.54],0.5281824669259444
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,12965,123,0.90 [0.60-1.34],0.603979266351496
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",12910,68,0.72 [0.39-1.33],0.293263768709771
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18951,1435,1.03 [0.93-1.14],0.5201377189270946
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13140,298,1.00 [0.79-1.26],0.9998985954303932
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13160,318,0.80 [0.61-1.05],0.1117608350617134
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13553,711,1.16 [1.02-1.32],0.027026770605892
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,12967,125,1.12 [0.81-1.56],0.4922488006799176
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19247,112,1.10 [0.78-1.55],0.5822411626976967
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13583,741,1.14 [1.00-1.30],0.0466617761017544
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13372,530,0.98 [0.82-1.17],0.8216546121784691
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17332,59,1.28 [0.85-1.94],0.2413097988207946
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18186,5344,0.99 [0.93-1.05],0.686148137060409
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17566,50,0.37 [0.16-0.87],0.0218947524146308
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17561,45,1.38 [0.93-2.07],0.1105592718052527
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19336,1535,0.99 [0.90-1.09],0.8641447408759271
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19334,1533,0.99 [0.90-1.10],0.8886937405607579
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17567,51,1.05 [0.61-1.78],0.8699080266805584
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19181,954,1.09 [0.97-1.23],0.1456253969626248
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14654,1812,1.04 [0.95-1.14],0.3611990909203294
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19468,242,0.87 [0.65-1.17],0.3588773549903546
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18209,92,1.11 [0.76-1.63],0.5760953964639495
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18327,100,0.72 [0.43-1.20],0.2056699192691758
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18370,143,0.65 [0.42-1.01],0.0543940236664461
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13001,159,0.79 [0.54-1.15],0.2157618120814088
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17153,150,0.96 [0.68-1.35],0.8218420559135877
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2068,81,0.98 [0.58-1.65],0.9438528743019526
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2202,248,0.98 [0.73-1.33],0.9192958058891592
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17070,67,1.09 [0.69-1.73],0.7055181926205369
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2035,49,0.81 [0.38-1.71],0.5796311194093829
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18799,1796,0.87 [0.78-0.96],0.0084641704648074
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18609,492,0.97 [0.81-1.17],0.7813363607926143
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17635,362,1.07 [0.87-1.31],0.5009969023657301
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13721,879,0.91 [0.78-1.06],0.2125966234537041
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19366,260,0.88 [0.67-1.16],0.3541696588867203
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18250,227,1.13 [0.89-1.44],0.3109523674268762
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,16885,1261,1.02 [0.91-1.14],0.7275589156222521
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18337,314,1.03 [0.83-1.30],0.7679730683986453
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18091,68,1.12 [0.72-1.76],0.6067646286670099
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18255,232,0.88 [0.65-1.18],0.3902059420760713
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9947,2320,1.04 [0.96-1.12],0.3220280411343071
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,AV-block,14946,545,0.96 [0.80-1.15],0.6469581630683395
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19408,464,0.93 [0.76-1.14],0.4826699141214577
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,7846,219,1.31 [1.06-1.61],0.0113008797857308
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14572,171,0.88 [0.63-1.24],0.4716428079214947
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14490,89,1.05 [0.70-1.58],0.8102650012904489
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19475,59,0.91 [0.52-1.61],0.7469257779901628
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,15667,1266,1.01 [0.90-1.13],0.8774749924230673
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17867,2263,0.97 [0.88-1.05],0.4408952919157149
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15777,7475,0.99 [0.95-1.04],0.6873481302077239
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18191,285,0.89 [0.69-1.15],0.37545596438492
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Endocarditis,14476,75,0.67 [0.36-1.23],0.196417913725218
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19241,1345,0.98 [0.88-1.09],0.7018940227289889
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,16804,6611,1.00 [0.95-1.05],0.923893872833063
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16810,6617,1.00 [0.95-1.05],0.9051403583473452
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19342,83,0.97 [0.61-1.52],0.8833850230573514
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10426,233,0.95 [0.71-1.26],0.7065849559399817
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10311,118,0.91 [0.60-1.37],0.6475826806754502
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,19330,1287,0.97 [0.86-1.09],0.5651226603172657
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18434,119,0.93 [0.63-1.38],0.7203359353895469
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18014,2390,1.01 [0.93-1.09],0.8894914224519024
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19071,651,1.04 [0.89-1.21],0.6338239483221977
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14823,422,1.03 [0.85-1.24],0.7988635265688004
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18926,879,0.97 [0.85-1.12],0.7124228181321086
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16380,756,1.03 [0.89-1.19],0.6639892020076329
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19368,158,1.02 [0.75-1.40],0.8941444629224052
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19441,343,1.07 [0.87-1.31],0.5062087156144699
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,17964,58,0.55 [0.26-1.15],0.114415049199998
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,18105,82,0.72 [0.40-1.26],0.249662564726843
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,14887,486,0.91 [0.74-1.11],0.3366022905224858
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18132,109,0.94 [0.62-1.43],0.7888636133817047
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18293,270,1.02 [0.80-1.30],0.8817075110788748
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14586,185,0.99 [0.74-1.34],0.9714992641199672
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,17992,86,0.77 [0.46-1.30],0.3321601760027013
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,17943,37,0.92 [0.45-1.87],0.8188079234431447
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17811,73,1.09 [0.70-1.68],0.7045971941309715
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18044,138,1.00 [0.72-1.39],0.9855675628075052
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15572,1171,0.93 [0.82-1.05],0.2328528284483632
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18093,50,0.56 [0.25-1.24],0.1549578377171309
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18617,594,1.17 [1.01-1.34],0.0315908279816318
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18832,448,0.97 [0.79-1.18],0.729440698360942
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18526,788,0.80 [0.67-0.94],0.0089138144120219
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7974,347,0.98 [0.79-1.23],0.8819732010091664
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18471,477,1.16 [0.99-1.36],0.0756339521691843
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18260,354,0.90 [0.72-1.13],0.3752928094404678
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18881,497,1.05 [0.88-1.25],0.5753633919217946
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19393,785,1.00 [0.87-1.16],0.967523558377469
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14830,429,1.06 [0.89-1.28],0.5109493714093062
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18828,444,0.96 [0.78-1.17],0.661070161360946
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,17950,212,0.77 [0.55-1.08],0.1330865813251984
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19055,740,1.01 [0.87-1.17],0.9011699900466164
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19044,773,1.03 [0.90-1.19],0.667904673667651
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18411,50,1.23 [0.78-1.93],0.3683126331468845
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18106,83,0.87 [0.53-1.43],0.5785075991885101
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18676,256,1.05 [0.83-1.34],0.6826340354150522
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18321,274,0.81 [0.61-1.08],0.1481423591500657
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,18323,417,0.93 [0.76-1.15],0.5182682598642832
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18039,98,0.78 [0.48-1.29],0.335663769901808
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19242,783,1.00 [0.87-1.15],0.9794961489296822
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19412,278,1.13 [0.91-1.40],0.2735161305202321
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16750,1165,1.00 [0.89-1.12],0.9759288405535488
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,19052,3467,1.00 [0.94-1.07],0.9700789131612092
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19387,327,1.06 [0.86-1.31],0.5788406001517968
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16759,1174,1.03 [0.92-1.15],0.6132784691375449
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15649,64,0.65 [0.33-1.27],0.2072463583312173
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,19059,974,1.05 [0.93-1.19],0.4165939818136336
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16789,1204,1.06 [0.95-1.19],0.279396794122183
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Vascular dementia,18784,192,0.79 [0.56-1.12],0.1809182694201678
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,19476,492,0.90 [0.74-1.10],0.2975049381637316
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12148,92,0.58 [0.33-1.05],0.071526491020501
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Bell's palsy,17959,71,1.19 [0.82-1.75],0.3576121401765405
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18297,409,0.99 [0.81-1.20],0.9018445832828184
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,19116,204,1.33 [1.10-1.61],0.0039387699642988
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19415,317,0.77 [0.58-1.01],0.0616411166844297
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18795,69,0.85 [0.49-1.47],0.5564581371219983
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19460,60,0.63 [0.32-1.27],0.1978863525842037
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",18981,69,1.26 [0.87-1.82],0.2276755348791163
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,18258,242,0.89 [0.67-1.18],0.4095064093818443
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19105,1089,1.01 [0.89-1.13],0.91212677937541
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19428,525,0.94 [0.78-1.13],0.5028464657661583
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18931,2785,0.97 [0.90-1.05],0.5130960350186791
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19180,44,0.67 [0.30-1.48],0.321208817280431
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,19358,260,0.78 [0.58-1.05],0.1064776038110422
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,18972,60,1.04 [0.64-1.71],0.8616792127649381
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19464,57,0.82 [0.44-1.52],0.530283911951098
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,17950,62,0.63 [0.32-1.24],0.1800372730586779
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,17952,64,0.95 [0.56-1.60],0.8357871226376422
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Memory loss,18575,129,0.90 [0.61-1.32],0.5875645196472593
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,18249,233,0.84 [0.63-1.13],0.259713379059892
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19436,212,0.77 [0.56-1.07],0.1256816119143192
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,12235,158,0.90 [0.64-1.28],0.5675489156412897
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19371,48,1.04 [0.61-1.80],0.8747473750403897
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18894,1006,0.97 [0.85-1.10],0.6026858882853756
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,18254,3439,0.95 [0.89-1.02],0.1702462082821377
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,18964,238,0.87 [0.65-1.16],0.3454473497522902
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18218,330,0.97 [0.77-1.21],0.7896492320946653
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19414,280,1.03 [0.82-1.30],0.8155479136222178
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14791,786,0.90 [0.77-1.05],0.1699363564949245
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,18980,68,0.65 [0.34-1.24],0.1916477119722677
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19041,129,0.65 [0.41-1.04],0.0706606800316909
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19080,177,1.09 [0.83-1.43],0.5281871460131898
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,17966,78,1.16 [0.79-1.70],0.4414895596776327
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,18062,46,1.55 [1.14-2.11],0.005166434451788
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,19384,472,1.07 [0.90-1.27],0.4315025494199028
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,18427,411,1.11 [0.94-1.32],0.2165851309844907
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,19446,330,0.88 [0.69-1.13],0.3239214899446377
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,18950,38,1.35 [0.88-2.09],0.1678875620647122
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,19475,77,0.96 [0.60-1.54],0.8715673906292846
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,19293,354,1.09 [0.90-1.31],0.3786142518367444
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19182,48,0.78 [0.39-1.58],0.4935517853994932
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19464,178,0.92 [0.66-1.26],0.5931776613237745
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,17946,58,0.69 [0.36-1.36],0.28643901868569
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19476,497,0.90 [0.74-1.10],0.3080984671136185
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18730,186,0.82 [0.58-1.16],0.2624221860891866
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,18946,126,0.99 [0.68-1.42],0.935144166633368
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19114,478,0.94 [0.78-1.14],0.5438507112951729
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19273,219,0.87 [0.64-1.18],0.3777407017934708
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18445,52,1.03 [0.60-1.75],0.9238495447563422
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18426,33,1.27 [0.75-2.15],0.3667634527678013
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19374,61,1.05 [0.64-1.72],0.8446826533733834
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19213,192,0.61 [0.41-0.91],0.0140554906398598
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2039,52,1.04 [0.55-1.94],0.9085376778266264
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2513,92,0.95 [0.58-1.54],0.8232823634850079
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,18909,89,1.19 [0.84-1.68],0.3228755227417419
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19242,1181,0.94 [0.83-1.07],0.3421904138436537
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19124,731,0.97 [0.83-1.13],0.6515121987345228
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18646,253,0.76 [0.55-1.03],0.0777451017849955
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19421,785,1.01 [0.88-1.16],0.8868551620773035
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19470,66,0.60 [0.31-1.18],0.1384543200994994
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19372,736,0.97 [0.84-1.13],0.731163846796693
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19444,423,0.75 [0.59-0.95],0.0174800599722392
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19377,188,0.94 [0.69-1.28],0.7035018749653472
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18480,87,0.83 [0.51-1.37],0.4696799406260769
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18479,86,1.17 [0.82-1.68],0.3894708604078586
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18458,65,0.95 [0.56-1.60],0.8374974219039542
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19365,849,1.10 [0.97-1.25],0.1304526160173337
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18751,235,1.00 [0.77-1.30],0.9825530175129914
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18690,54,1.27 [0.83-1.95],0.272196806359037
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19125,104,0.73 [0.44-1.19],0.2016309809949765
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19351,330,0.72 [0.55-0.95],0.0213762133682023
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18820,184,0.98 [0.72-1.32],0.8862452501007434
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19306,117,0.78 [0.50-1.23],0.2859829628097045
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19068,552,1.02 [0.86-1.21],0.847937185653843
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,18952,132,0.93 [0.64-1.34],0.686445622780699
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17450,2715,1.03 [0.96-1.12],0.3750385234953144
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19315,294,0.70 [0.52-0.94],0.0181883405765488
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19461,159,1.11 [0.84-1.47],0.4678799946010034
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18844,451,1.09 [0.92-1.30],0.3212828096962488
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19097,76,0.82 [0.48-1.41],0.4741985878602807
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19463,59,0.66 [0.33-1.31],0.2321868417734077
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18499,106,0.98 [0.66-1.46],0.9399333055983854
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18545,152,1.06 [0.78-1.44],0.6884816969875056
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18195,134,1.04 [0.75-1.45],0.7986171812945643
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18679,43,1.50 [1.05-2.13],0.0248957873135314
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18122,61,1.07 [0.67-1.73],0.771476010489589
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18613,97,1.44 [1.12-1.86],0.0047890786878379
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18759,243,1.11 [0.88-1.41],0.3757146840976902
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18517,124,1.05 [0.75-1.48],0.7605347808288068
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18138,77,1.02 [0.66-1.59],0.927635818816974
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18165,104,0.79 [0.49-1.26],0.3168730192906025
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,16987,2252,1.02 [0.94-1.11],0.6193713051384686
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18472,79,0.89 [0.54-1.47],0.6576650930889002
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19235,415,0.96 [0.78-1.18],0.685702024741405
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,18884,64,0.89 [0.51-1.56],0.6801100775943842
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),18980,160,0.91 [0.64-1.28],0.5781012402336329
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19280,91,0.92 [0.59-1.45],0.7210324111780457
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19440,120,0.99 [0.69-1.44],0.9773325693708236
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19368,95,1.06 [0.72-1.56],0.7656800050025216
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19246,57,1.31 [0.90-1.92],0.1566441126505924
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19249,60,1.05 [0.65-1.71],0.8369800688313238
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19383,984,0.98 [0.86-1.11],0.7393041875205251
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19147,748,0.94 [0.81-1.10],0.4478062043063691
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18523,124,0.96 [0.66-1.40],0.8204791668622814
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18471,72,1.36 [0.98-1.87],0.062061769499563
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19310,52,1.30 [0.88-1.92],0.1880458006454344
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19408,150,1.12 [0.84-1.49],0.438796465870413
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19308,50,0.66 [0.31-1.39],0.2732662238175055
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza,17314,122,1.15 [0.84-1.56],0.3948087249518545
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17311,119,1.17 [0.86-1.59],0.3183150596244016
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12093,81,1.11 [0.74-1.64],0.6190929804705771
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19392,198,0.95 [0.71-1.28],0.7444637242733738
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13161,1462,1.05 [0.95-1.16],0.3368892970525726
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13458,1446,1.04 [0.94-1.15],0.4014665189237612
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19049,149,1.14 [0.85-1.52],0.3773995090980592
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17275,83,0.99 [0.63-1.55],0.9654157521155304
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,16308,428,1.03 [0.86-1.24],0.740025078823029
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",15939,59,0.96 [0.56-1.63],0.874114147767456
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18537,2657,1.04 [0.96-1.12],0.3569549139701621
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18448,66,0.72 [0.39-1.34],0.3013074886508705
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18493,111,1.23 [0.92-1.66],0.1619391651275894
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19234,1351,1.06 [0.95-1.17],0.3019268890608212
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18451,69,0.93 [0.56-1.55],0.7793371523575051
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17673,5065,1.02 [0.96-1.08],0.5180010035381495
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18670,288,0.91 [0.71-1.18],0.4869666474187023
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,17980,97,1.30 [0.99-1.71],0.058606371083776
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Emphysema,16247,367,0.96 [0.78-1.20],0.7453240995725685
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18361,392,1.11 [0.93-1.33],0.2567476825985197
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19255,2063,1.02 [0.93-1.11],0.722130383754452
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18395,426,1.12 [0.94-1.33],0.2048929064341329
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Later onset COPD,19030,1254,1.03 [0.92-1.15],0.6159175935039495
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19461,372,1.15 [0.96-1.38],0.1253774316586004
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,18466,84,0.99 [0.64-1.53],0.9574106795940438
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19237,1041,0.92 [0.80-1.05],0.1945075313087906
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19236,2214,1.02 [0.93-1.10],0.7178935235599315
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19016,634,0.94 [0.80-1.12],0.4946571956051946
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,17072,50,1.04 [0.60-1.79],0.9014899766541342
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19360,504,1.11 [0.94-1.30],0.2214450813456071
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19365,1416,1.03 [0.93-1.14],0.5956802414647124
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,18122,1100,1.01 [0.89-1.14],0.9030424963693494
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural plaque,17238,216,0.88 [0.65-1.19],0.4048130738580332
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19020,1828,1.02 [0.93-1.12],0.6720793568775734
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19367,278,1.16 [0.94-1.42],0.1752119234856843
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumothorax,17172,150,0.94 [0.66-1.33],0.7148072959110093
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pollen allergy,19467,166,0.86 [0.61-1.22],0.406026911848631
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,18932,76,1.14 [0.76-1.71],0.528780276538201
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12069,57,1.03 [0.62-1.72],0.9120239860601648
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19223,1027,0.92 [0.80-1.05],0.2002377792160158
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18581,199,0.94 [0.70-1.27],0.6857354550088178
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,17435,243,1.00 [0.77-1.30],0.9821556343644244
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19061,195,0.84 [0.60-1.17],0.2975768422287738
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6296,97,1.04 [0.70-1.55],0.8529231739240792
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12455,53,1.18 [0.74-1.88],0.4900109411884857
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,19375,109,1.24 [0.93-1.66],0.1436717040063631
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute gastritis,13619,82,0.96 [0.61-1.51],0.8487987545555171
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,17788,164,0.86 [0.60-1.22],0.3886058676291708
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,19080,92,0.73 [0.43-1.23],0.2410466898384507
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18648,48,1.32 [0.87-2.00],0.1920094913299712
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,13954,417,1.04 [0.87-1.26],0.6530098534297413
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17745,121,1.17 [0.87-1.58],0.3103389872889544
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19132,121,1.18 [0.88-1.59],0.2751712713835106
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,17800,176,1.16 [0.90-1.50],0.2400019510117506
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,18499,875,0.92 [0.80-1.07],0.2854911455246302
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,13823,286,0.84 [0.63-1.10],0.1987163991877814
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17668,44,0.37 [0.15-0.94],0.0374858574960717
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19365,106,1.11 [0.79-1.57],0.547733452719809
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,18034,103,1.40 [1.09-1.80],0.0092465946865886
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,18012,88,0.67 [0.38-1.16],0.151908652308156
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19377,140,0.97 [0.69-1.38],0.8841608494129926
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,19241,1719,0.96 [0.87-1.06],0.4222795235790656
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,17991,67,0.96 [0.58-1.60],0.8855782934753121
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19184,52,1.07 [0.63-1.79],0.8124335204415737
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,17985,61,1.10 [0.69-1.74],0.6865208007222285
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,18954,159,1.01 [0.73-1.38],0.970908803137222
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16880,2138,0.97 [0.89-1.06],0.5237303847488431
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,19401,135,1.27 [0.98-1.63],0.0691314913868841
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,19381,781,1.05 [0.91-1.20],0.5062030768620247
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17361,3824,0.98 [0.91-1.04],0.4671086142740724
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19193,398,0.98 [0.80-1.20],0.857263565686219
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19402,414,0.93 [0.76-1.15],0.5183232687291492
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18872,77,0.71 [0.39-1.26],0.2390705248738382
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18768,46,0.99 [0.54-1.80],0.9687373242593568
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19205,1274,1.05 [0.95-1.17],0.3539151244766583
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,18779,77,1.52 [1.17-1.97],0.0014889368273835
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18891,1267,0.94 [0.83-1.06],0.3000991796752144
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15579,3177,0.99 [0.92-1.06],0.8062201424951774
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,13736,199,0.80 [0.57-1.13],0.2083101833989671
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19393,160,0.71 [0.47-1.06],0.0935479434534232
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19448,19,0.46 [0.12-1.78],0.2598985499771808
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18724,124,1.02 [0.72-1.45],0.8953138525482827
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12496,94,0.77 [0.46-1.28],0.3145767599043398
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,14013,476,0.96 [0.80-1.16],0.6973433711082369
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,13894,357,1.05 [0.86-1.28],0.635245458514457
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15754,2217,0.98 [0.89-1.06],0.5673466829545821
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14073,536,0.96 [0.80-1.15],0.6321054731605753
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14141,6909,1.00 [0.95-1.04],0.8470468920926904
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,18978,1047,1.04 [0.92-1.17],0.5038613566771127
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18839,44,0.85 [0.43-1.69],0.6467257017379436
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13223,981,1.09 [0.97-1.23],0.1280148251877918
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18656,56,0.70 [0.35-1.40],0.3100256163008858
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,17771,3029,0.96 [0.89-1.03],0.280323275501906
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,19450,18,0.49 [0.13-1.92],0.3058471623255062
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,12464,62,0.64 [0.33-1.26],0.1969462183038223
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,15659,917,1.01 [0.89-1.15],0.8758269166478
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14839,97,0.98 [0.64-1.48],0.9055176967534648
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12501,99,0.96 [0.63-1.46],0.8560479542884073
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18053,122,1.31 [1.01-1.70],0.0398407799864167
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12830,428,0.90 [0.73-1.11],0.3354985453437673
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19453,277,1.05 [0.84-1.32],0.656609338778241
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18583,659,1.00 [0.85-1.16],0.957466267073025
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18839,915,1.00 [0.88-1.14],0.9945561843139994
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13719,182,1.11 [0.86-1.45],0.4247459062557082
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,14126,589,1.10 [0.95-1.28],0.187745413350676
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19428,113,0.81 [0.52-1.27],0.3633929927556484
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14812,70,1.03 [0.65-1.63],0.9140270352650884
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13560,1158,1.01 [0.90-1.13],0.9042931097723044
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17921,297,1.03 [0.82-1.29],0.7965605186636266
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17745,121,0.96 [0.66-1.39],0.8208846420925954
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14009,1607,0.96 [0.86-1.07],0.4426422583015974
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,17545,5143,0.98 [0.92-1.03],0.4098102528898878
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18752,181,0.84 [0.60-1.19],0.3319439232737276
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,19246,646,1.10 [0.95-1.26],0.2052499097363054
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14177,640,1.04 [0.90-1.21],0.5896225214803044
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17800,176,0.92 [0.67-1.28],0.6257625197211929
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19337,349,0.95 [0.76-1.19],0.6536718913386647
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14461,924,0.96 [0.84-1.10],0.592518893802793
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18990,1059,1.05 [0.94-1.18],0.3875029372858853
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18944,149,1.23 [0.95-1.59],0.1242796404803555
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14158,1756,0.96 [0.86-1.06],0.3704498418018753
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15339,1802,1.01 [0.92-1.11],0.861083984723045
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18696,96,0.83 [0.52-1.33],0.4366534025954759
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18737,813,0.96 [0.83-1.11],0.6240710787039367
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12767,365,0.98 [0.79-1.21],0.8412039743527548
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19445,23,0.88 [0.35-2.22],0.7927181724759602
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12914,512,0.93 [0.77-1.12],0.4453581583204758
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18068,137,0.84 [0.57-1.25],0.3985690725176631
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19464,43,1.36 [0.90-2.05],0.1483246936197781
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18789,83,1.24 [0.87-1.75],0.2352281252438535
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Toxic colitis,17993,69,1.11 [0.73-1.71],0.6219886775351738
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13830,293,1.00 [0.80-1.27],0.974381829200008
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18058,134,1.15 [0.86-1.54],0.3474739541308091
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18031,107,1.24 [0.93-1.65],0.1367809478050526
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,14949,207,0.88 [0.64-1.20],0.4187467462842926
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12603,201,0.85 [0.61-1.18],0.3264602055736749
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,14968,226,0.81 [0.59-1.12],0.2027557886915742
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Volvulus,12477,75,0.58 [0.30-1.10],0.0940898815516885
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19388,340,1.02 [0.82-1.26],0.8588067703397493
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19174,61,1.20 [0.81-1.79],0.3640065873251232
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17389,142,0.91 [0.64-1.31],0.6176512448735265
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18960,686,0.88 [0.74-1.04],0.1447625010724355
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18391,117,0.75 [0.47-1.18],0.217136585715338
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17730,483,1.06 [0.89-1.26],0.5047018108861705
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19186,259,0.97 [0.75-1.25],0.810007496481694
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19385,458,1.06 [0.89-1.26],0.5357273779405565
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,18970,43,1.07 [0.61-1.88],0.8216733335995691
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18127,3082,0.98 [0.91-1.05],0.5252622376399732
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19109,369,1.08 [0.89-1.31],0.4146632433015687
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,18997,257,1.03 [0.81-1.31],0.8023029631113681
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19158,884,0.89 [0.77-1.03],0.1246833650368737
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19459,51,0.83 [0.44-1.58],0.5693113900860614
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17302,55,1.01 [0.59-1.72],0.9822386860337078
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18793,53,1.44 [1.03-2.01],0.0351566319508897
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19174,247,0.98 [0.75-1.27],0.8652829715759818
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17748,501,0.91 [0.75-1.10],0.3343518933563155
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17326,79,0.61 [0.33-1.12],0.1095207577480966
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19407,72,1.22 [0.84-1.77],0.3031132321354661
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18448,174,1.12 [0.86-1.47],0.4046132284117609
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19300,187,1.05 [0.80-1.39],0.7254324828176411
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,18999,72,1.34 [0.97-1.87],0.0799623916159001
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17307,60,0.80 [0.43-1.48],0.4684336442429506
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18960,1713,0.98 [0.89-1.09],0.7489327827554355
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17786,539,0.89 [0.74-1.08],0.2357232282435062
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17328,81,0.60 [0.33-1.10],0.1008366425748085
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19398,285,0.98 [0.78-1.25],0.9007134654144734
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,18992,65,1.08 [0.69-1.70],0.7293926152180867
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19346,233,1.01 [0.78-1.31],0.930967852363434
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19416,368,1.02 [0.83-1.25],0.8739283148669588
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17354,107,0.73 [0.45-1.18],0.2015122405035782
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17521,274,0.97 [0.75-1.24],0.7777241012509354
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19405,357,1.00 [0.81-1.23],0.9773923873079434
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17505,258,1.02 [0.80-1.30],0.8994701924723048
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19454,119,1.20 [0.89-1.61],0.230370764300579
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16245,66,1.13 [0.74-1.73],0.5759022136893119
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17184,5378,0.99 [0.93-1.04],0.6157576710894879
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16004,4198,0.98 [0.92-1.04],0.5727864810157175
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16224,45,1.19 [0.73-1.93],0.4886865319717228
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16229,118,0.67 [0.41-1.09],0.1034288737368944
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16268,157,1.03 [0.75-1.40],0.870165301344633
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19256,50,1.17 [0.73-1.88],0.5106461545138892
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16235,124,0.61 [0.38-1.00],0.0479125559995768
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13057,1251,1.02 [0.92-1.14],0.7198001706862684
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19290,209,1.16 [0.92-1.47],0.1972788394819261
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16574,463,0.94 [0.78-1.15],0.5689176876862909
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15786,6725,0.99 [0.94-1.04],0.6037006831981869
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17398,102,1.10 [0.78-1.56],0.5919796761318366
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16326,147,1.13 [0.84-1.51],0.4169631960321975
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16610,431,0.87 [0.71-1.08],0.2171021298158206
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18690,2579,1.01 [0.93-1.09],0.8005636880243615
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16446,267,0.82 [0.61-1.09],0.1704535165059299
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16300,121,1.13 [0.83-1.53],0.4377385031931251
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16278,99,1.02 [0.69-1.50],0.9380182002165354
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18823,87,1.00 [0.65-1.55],0.988701640630702
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13485,1679,0.99 [0.90-1.09],0.866544925271298
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12438,632,0.96 [0.81-1.14],0.6384513672756533
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19398,626,0.94 [0.80-1.11],0.4822263597295938
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11865,59,1.29 [0.89-1.86],0.1817695123430381
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12066,260,0.87 [0.67-1.14],0.3216744378790193
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16403,224,1.13 [0.90-1.42],0.2937521879885014
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12216,410,0.99 [0.82-1.20],0.9286450379080547
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16174,63,0.91 [0.52-1.58],0.7331452563555789
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16671,560,0.93 [0.77-1.11],0.4027452237675828
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16364,253,0.91 [0.69-1.20],0.5026517182830189
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12190,384,1.02 [0.84-1.24],0.8683730365188652
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16237,58,0.90 [0.51-1.59],0.7102612486424611
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16227,48,0.65 [0.30-1.40],0.2764752470361213
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17361,65,0.73 [0.39-1.36],0.3218699324056349
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19122,1826,0.89 [0.81-0.99],0.0314640471739912
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18584,1288,0.88 [0.78-1.00],0.0510746912288223
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19335,452,0.93 [0.76-1.13],0.4592942765555199
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14406,2600,0.94 [0.86-1.02],0.113966043540144
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11845,39,0.89 [0.45-1.77],0.7394435106232096
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16263,84,1.02 [0.67-1.56],0.9313108121078526
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11872,66,0.93 [0.54-1.59],0.7880626867462481
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11919,113,0.95 [0.65-1.39],0.7785999119808213
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17501,205,0.99 [0.75-1.31],0.9465797641008628
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17697,401,0.94 [0.76-1.15],0.5401701780045869
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19459,88,0.71 [0.42-1.23],0.2226341575276037
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17742,1631,0.96 [0.87-1.07],0.4840907222921521
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16238,59,1.15 [0.74-1.79],0.5343219148876532
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11931,125,0.93 [0.64-1.34],0.6974812193032542
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16766,655,0.91 [0.76-1.07],0.2522967380551229
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13619,1813,0.97 [0.88-1.07],0.5537266210822767
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18841,105,1.07 [0.74-1.54],0.7377717947655735
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19469,58,1.20 [0.79-1.81],0.3946291117997736
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16245,66,1.13 [0.74-1.74],0.5765511653118611
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17291,1112,1.00 [0.89-1.12],0.9598465399027664
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16264,85,1.09 [0.73-1.63],0.6584460166449251
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13542,1736,0.98 [0.88-1.08],0.6130037317534152
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17399,103,0.88 [0.57-1.36],0.5616356930730209
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16206,27,0.81 [0.33-1.98],0.6389925203064393
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16273,162,1.04 [0.77-1.40],0.8081134051735012
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16735,556,1.11 [0.96-1.29],0.1729316017009428
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19154,418,0.93 [0.75-1.14],0.4837944948017645
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16655,544,0.95 [0.79-1.14],0.5585591271256027
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19346,447,0.93 [0.76-1.14],0.4972577314019883
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19457,57,1.00 [0.59-1.69],0.9962366781607446
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16318,139,0.87 [0.60-1.27],0.480589779554422
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15159,718,0.83 [0.70-0.99],0.0350694473541938
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16712,533,0.85 [0.70-1.03],0.0985776342860792
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16420,241,0.83 [0.62-1.12],0.234927449610813
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11869,63,1.42 [1.06-1.92],0.0204887045858207
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14408,2602,0.99 [0.91-1.07],0.757862296043491
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12503,697,0.91 [0.77-1.07],0.2412404599312863
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19048,312,0.86 [0.66-1.11],0.2456698336678894
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19430,59,0.70 [0.36-1.36],0.2977538826719028
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17262,58,0.75 [0.39-1.44],0.3899282577894837
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11865,59,1.19 [0.79-1.80],0.3973973103292874
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16200,89,0.78 [0.47-1.31],0.3480616681266312
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12265,459,0.95 [0.79-1.16],0.6330262580365791
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16460,281,0.94 [0.73-1.21],0.6168988038650057
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16348,237,1.00 [0.77-1.30],0.9778815908889708
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16322,211,0.99 [0.75-1.31],0.9449360114061331
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13729,60,0.82 [0.45-1.52],0.5354525078778831
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19460,60,0.99 [0.59-1.65],0.956132092006872
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16645,466,1.04 [0.88-1.24],0.6300990503340864
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],18820,84,1.11 [0.75-1.63],0.6131664406218731
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18378,2199,0.99 [0.91-1.08],0.7710546924808037
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16300,121,0.67 [0.42-1.08],0.099508166425688
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16682,571,0.93 [0.78-1.11],0.4117254005336528
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18313,221,0.94 [0.71-1.25],0.674334709340547
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16308,197,1.02 [0.77-1.35],0.8738261723934636
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17736,1625,0.99 [0.90-1.10],0.8604824239890927
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17170,1059,1.03 [0.91-1.16],0.6624444878341318
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16227,48,0.92 [0.50-1.71],0.8011023478468027
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18843,107,1.05 [0.73-1.51],0.8097059558127975
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16324,145,0.80 [0.54-1.18],0.253788199467523
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16256,77,0.78 [0.45-1.34],0.3621248176277323
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11865,59,0.71 [0.37-1.37],0.3098767673072827
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18368,1782,0.98 [0.89-1.08],0.7366089678960247
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7867,22,0.42 [0.12-1.48],0.1763331890634006
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,9980,27,0.70 [0.27-1.84],0.4709054180222535
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19205,260,1.09 [0.87-1.36],0.4688980186825044
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19035,90,1.42 [1.09-1.84],0.0094482691288563
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18294,1708,1.00 [0.91-1.10],0.9618836207285848
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19296,85,1.11 [0.76-1.63],0.5824406688611501
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19258,325,0.95 [0.75-1.20],0.6689460357035523
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,16346,245,0.98 [0.75-1.27],0.8725178102299561
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,16653,67,1.19 [0.80-1.76],0.4009761269235121
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8514,1767,0.99 [0.90-1.09],0.8913899872755362
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10060,107,0.66 [0.40-1.09],0.1062959254968644
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,7878,33,0.46 [0.17-1.27],0.1350708663815274
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8329,484,1.06 [0.89-1.26],0.5449710047855287
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16088,5172,1.01 [0.95-1.07],0.7466478936889969
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19278,67,1.18 [0.79-1.77],0.421532618210591
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,6850,103,0.92 [0.60-1.42],0.7170573896436412
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16618,273,0.91 [0.70-1.18],0.4822079763924023
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8243,1496,0.98 [0.88-1.09],0.7572860628599831
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10114,133,1.06 [0.77-1.46],0.7103003761120668
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6853,106,0.89 [0.57-1.37],0.5836781420055328
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16171,70,0.47 [0.23-0.95],0.0346050784699229
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8708,863,1.02 [0.89-1.17],0.7390892003901366
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6799,52,1.36 [0.94-1.98],0.1000385265716466
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7877,32,0.95 [0.45-2.03],0.8977975627249705
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19470,73,0.89 [0.53-1.49],0.6478967401507624
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19466,67,0.97 [0.59-1.61],0.919475204488046
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18477,2376,0.96 [0.88-1.05],0.3621976275820296
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16886,785,0.94 [0.81-1.10],0.4572263744640594
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,9998,45,0.48 [0.21-1.13],0.095155556417423
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19418,485,1.00 [0.84-1.20],0.9827146510407074
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6869,122,0.79 [0.51-1.23],0.2953453477365897
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6879,132,0.91 [0.62-1.33],0.6214394303223696
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6870,123,1.06 [0.75-1.49],0.7476742547266466
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19447,68,1.41 [1.03-1.92],0.031465563915031
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17950,1849,0.97 [0.89-1.07],0.5977648192721694
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10051,70,1.18 [0.81-1.72],0.396090076526682
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7909,64,0.57 [0.29-1.13],0.1074051285313987
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",7978,133,0.98 [0.68-1.41],0.9178658731051887
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7891,46,1.10 [0.64-1.89],0.729178635178132
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7930,85,0.67 [0.38-1.18],0.1693287316988819
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16665,320,0.95 [0.76-1.20],0.6771989584974963
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19091,158,1.10 [0.83-1.47],0.5053946084316681
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7950,105,1.29 [0.95-1.75],0.0993297871101703
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7866,21,1.14 [0.53-2.46],0.7399302860461949
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8026,181,1.13 [0.87-1.48],0.3607191514997961
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7927,82,0.39 [0.20-0.76],0.0058124334761543
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8022,177,0.79 [0.55-1.13],0.1945396744450268
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19256,45,0.99 [0.54-1.81],0.9628663203232192
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6871,124,0.87 [0.58-1.31],0.5130726051092719
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19279,2934,1.00 [0.93-1.08],0.9968057027176964
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16420,75,0.88 [0.53-1.46],0.6160066960202673
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16719,133,1.24 [0.95-1.61],0.1106173319932491
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,18978,33,0.87 [0.40-1.89],0.7171242776707486
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16326,225,1.05 [0.82-1.36],0.6966251042387732
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19282,337,1.14 [0.94-1.37],0.1851960890713874
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7879,34,1.25 [0.71-2.18],0.4349270082223532
